Femme et Homme
- | Pays :
- United States
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this study is to assess the bioequivalence of a new oxycodone formulation (40 mg) relative to the original OxyContin® (OXY) formulation (40 mg) in the fasted state.
Critère d'inclusion
- Healthy